A government-sponsored study published recently in The Open Neurology Journal concludes that cannabis provides relief to some chronic pain sufferers and that more clinical trials are needed—directly challenging DEA classification of the drug under "Schedule I," that reserved for substances with no medical uses. The study, sponsored by the State of California and conducted at the University of California Center for Medicinal Cannabis Research, calls the Schedule I placement "not accurate" and "not tenable."
Recent comments
1 week 11 hours ago
5 weeks 21 hours ago
6 weeks 1 day ago
6 weeks 1 day ago
27 weeks 1 day ago
31 weeks 2 days ago
33 weeks 2 hours ago
33 weeks 21 hours ago
45 weeks 3 days ago
51 weeks 1 day ago